jCyte Announces Appointment of Dr. Adam Walsh as Chief Financial Officer

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced the further expansion of the company’s executive management team with the appointment of Adam Walsh, M.D. as Chief Financial Officer. Dr. Walsh brings to jCyte over two decades of...

Click to view original post